Bioprinting Breast Cancer In Situ to Study Cell Communication in Disease Progression

Claire Robertson | 18-ERD-062

Executive Summary

We will develop high-fidelity epithelial culture models of early stage, non-invasive human breast cancer, which will be used to understand malignant progression and to improve prediction of biological response to carcinogenic pathogens or chemical challenges.

Publications, Presentations, Etc.

Robertson, C. 2019. "The Microstructure of Laminin-111 Compensates for Dystroglycan Loss in Mammary Epithelial Cells in Downstream Expression of Milk Proteins." Biomaterials 218: 119337. doi: 10.1016/j.biomaterials.2019.119337. LLNL-JRNL-766544.